Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12564 | 834 | 38.0 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2012 | 4981 | PLATELET ACTIVATING FACTOR//LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2//PAF |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | Author keyword | 152 | 70% | 15% | 126 |
2 | LP PLA2 | Author keyword | 104 | 75% | 9% | 75 |
3 | PAF ACETYLHYDROLASE | Author keyword | 38 | 51% | 6% | 53 |
4 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | Author keyword | 37 | 48% | 7% | 57 |
5 | PLA2G7 | Author keyword | 23 | 100% | 1% | 10 |
6 | DARAPLADIB | Author keyword | 21 | 65% | 2% | 20 |
7 | PAF AH | Author keyword | 13 | 53% | 2% | 17 |
8 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 LP PLA2 | Author keyword | 8 | 70% | 1% | 7 |
9 | LP PLA2 INHIBITOR | Author keyword | 8 | 100% | 1% | 5 |
10 | ACETYLHYDROLASE | Author keyword | 8 | 36% | 2% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | 152 | 70% | 15% | 126 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 |
2 | LP PLA2 | 104 | 75% | 9% | 75 | Search LP+PLA2 | Search LP+PLA2 |
3 | PAF ACETYLHYDROLASE | 38 | 51% | 6% | 53 | Search PAF+ACETYLHYDROLASE | Search PAF+ACETYLHYDROLASE |
4 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | 37 | 48% | 7% | 57 | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE |
5 | PLA2G7 | 23 | 100% | 1% | 10 | Search PLA2G7 | Search PLA2G7 |
6 | DARAPLADIB | 21 | 65% | 2% | 20 | Search DARAPLADIB | Search DARAPLADIB |
7 | PAF AH | 13 | 53% | 2% | 17 | Search PAF+AH | Search PAF+AH |
8 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 LP PLA2 | 8 | 70% | 1% | 7 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2+LP+PLA2 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2+LP+PLA2 |
9 | LP PLA2 INHIBITOR | 8 | 100% | 1% | 5 | Search LP+PLA2+INHIBITOR | Search LP+PLA2+INHIBITOR |
10 | ACETYLHYDROLASE | 8 | 36% | 2% | 17 | Search ACETYLHYDROLASE | Search ACETYLHYDROLASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACTIVATING FACTOR ACETYLHYDROLASE | 87 | 37% | 22% | 187 |
2 | PAF ACETYLHYDROLASE | 74 | 67% | 8% | 67 |
3 | FACTOR PAF ACETYLHYDROLASE | 47 | 86% | 3% | 24 |
4 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | 37 | 67% | 4% | 33 |
5 | LP PLA2 | 34 | 93% | 2% | 13 |
6 | PLASMA PAF ACETYLHYDROLASE | 33 | 83% | 2% | 19 |
7 | FACTOR ACETYLHYDROLASE ACTIVITY | 24 | 52% | 4% | 33 |
8 | FACTOR 1 0 ALKYL 2 ACETYL SN GLYCERO 3 PHOSPHOCHOLINE | 21 | 73% | 2% | 16 |
9 | PAF AH | 21 | 73% | 2% | 16 |
10 | FACTOR ACETYLHYDROLASE | 17 | 21% | 9% | 72 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A(2)) | 2009 | 88 | 98 | 78% |
Lp-PLA(2)- a novel risk factor for high-risk coronary and carotid artery disease | 2011 | 23 | 71 | 87% |
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A(2) | 2012 | 30 | 168 | 64% |
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma | 2009 | 58 | 135 | 59% |
Platelet-activating factor acetylhydrolases | 1997 | 176 | 48 | 67% |
Lipoprotein-associated phospholipase A(2) and atherosclerosis | 2009 | 48 | 34 | 65% |
Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker | 2012 | 15 | 80 | 75% |
Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)): a review | 2011 | 16 | 76 | 64% |
Lipoprotein-associated phospholipase A(2) as a biomarker of coronary heart disease and a therapeutic target | 2009 | 23 | 42 | 90% |
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A(2) as a cardiovascular risk marker | 2008 | 55 | 38 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SCI NUTR DIETET | 6 | 32% | 1.8% | 15 |
2 | BASIC PL UNIT | 4 | 75% | 0.4% | 3 |
3 | SW MED BIOCHEM 5323 HARRY HINES BLVD | 3 | 50% | 0.5% | 4 |
4 | LEADING CLIN NUTRIGENET NUTRIGENOM | 2 | 67% | 0.2% | 2 |
5 | CARDIOVASC EXCELLENCE DRUG DISCOVERY | 2 | 43% | 0.4% | 3 |
6 | BAYLOR LIPID ATHEROSCLEROSIS CLIN | 1 | 100% | 0.2% | 2 |
7 | CLIN SCIINTERNAL MED GRP | 1 | 100% | 0.2% | 2 |
8 | SEOUL EULJI HOSP MED | 1 | 100% | 0.2% | 2 |
9 | LIPID METAB ATHEROSCLEROSIS | 1 | 12% | 1.2% | 10 |
10 | NESCO CO | 1 | 33% | 0.4% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000187899 | PLATELET ACTIVATING FACTOR//PAF//JOURNAL OF LIPID MEDIATORS |
2 | 0.0000173222 | EARLY PREGNANCY FACTOR//ROSETTE INHIBITION TEST//PREIMPLANTATION FACTOR |
3 | 0.0000150839 | OXIDIZED PHOSPHOLIPIDS//LEVUGLANDIN//OX PAPC |
4 | 0.0000108896 | LYSOPHOSPHATIDYLCHOLINE//G2A//TDAG8 |
5 | 0.0000065270 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
6 | 0.0000061664 | PHOSPHOLIPASE A2//SECRETORY PHOSPHOLIPASE A2//CYTOSOLIC PHOSPHOLIPASE A2 |
7 | 0.0000060629 | C REACTIVE PROTEIN//HIGH SENSITIVITY C REACTIVE PROTEIN//CARDIOVASC DIS PREVENT |
8 | 0.0000041678 | OXIDIZED LDL//LOW DENSITY LIPOPROTEIN//LIPOPROTEIN OXIDATION |
9 | 0.0000041492 | PARAOXONASE//PARAOXONASE 1//PON1 |
10 | 0.0000035441 | TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB |